---
layout: default
title: Adaptive Identification and Modeling of Clinical Pathways with Process Mining
---

# Adaptive Identification and Modeling of Clinical Pathways with Process Mining

**arXiv**: [2512.03787v1](https://arxiv.org/abs/2512.03787) | [PDF](https://arxiv.org/pdf/2512.03787.pdf)

**ä½œè€…**: Francesco Vitale, Nicola Mazzocca

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºåŸºäºŽè¿‡ç¨‹æŒ–æŽ˜çš„ä¸¤é˜¶æ®µå»ºæ¨¡æ–¹æ³•ï¼Œä»¥è‡ªé€‚åº”è¯†åˆ«å’Œå»ºæ¨¡ä¸´åºŠè·¯å¾„ï¼Œè§£å†³æ‰‹åŠ¨å»ºæ¨¡å›°éš¾é—®é¢˜ã€‚**

**å…³é”®è¯**: `ä¸´åºŠè·¯å¾„å»ºæ¨¡` `è¿‡ç¨‹æŒ–æŽ˜` `ä¸€è‡´æ€§æ£€æŸ¥` `è‡ªé€‚åº”å»ºæ¨¡` `åŒ»ç–—æ•°æ®åˆ†æž`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ ¸å¿ƒé—®é¢˜ï¼šæ‰‹åŠ¨å»ºæ¨¡ä¸´åºŠè·¯å¾„å›°éš¾ï¼Œéš¾ä»¥åæ˜ ç–¾ç—…å˜ä½“æˆ–ç»„åˆçš„å®žé™…æœ€ä½³å®žè·µã€‚
2. æ–¹æ³•è¦ç‚¹ï¼šä½¿ç”¨è¿‡ç¨‹æŒ–æŽ˜ï¼Œé€šè¿‡åŽ†å²æ•°æ®æž„å»ºå‚è€ƒæ¨¡åž‹ï¼Œå¹¶åŸºäºŽæ–°æ•°æ®éªŒè¯ä¸€è‡´æ€§ä»¥æ‰©å±•çŸ¥è¯†åº“ã€‚
3. å®žéªŒæˆ–æ•ˆæžœï¼šåœ¨Syntheaæ•°æ®é›†ä¸ŠéªŒè¯ï¼ŒAUCå³°å€¼è¾¾95.62%ï¼Œå¼§åº¦ç®€æ´åº¦ä¸º67.11%ã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Clinical pathways are specialized healthcare plans that model patient treatment procedures. They are developed to provide criteria-based progression and standardize patient treatment, thereby improving care, reducing resource use, and accelerating patient recovery. However, manual modeling of these pathways based on clinical guidelines and domain expertise is difficult and may not reflect the actual best practices for different variations or combinations of diseases. We propose a two-phase modeling method using process mining, which extends the knowledge base of clinical pathways by leveraging conformance checking diagnostics. In the first phase, historical data of a given disease is collected to capture treatment in the form of a process model. In the second phase, new data is compared against the reference model to verify conformance. Based on the conformance checking results, the knowledge base can be expanded with more specific models tailored to new variants or disease combinations. We demonstrate our approach using Synthea, a benchmark dataset simulating patient treatments for SARS-CoV-2 infections with varying COVID-19 complications. The results show that our method enables expanding the knowledge base of clinical pathways with sufficient precision, peaking to 95.62% AUC while maintaining an arc-degree simplicity of 67.11%.

